Abstract
Saturated and mono-unsaturated fatty acids exert differential effects on pancreatic β-cell viability during chronic exposure. Long chain saturated molecules (e.g. palmitate) are cytotoxic to β-cells and this is associated with caspase activation and induction of apoptosis. By contrast, mono-unsaturated fatty acids (e.g. palmitoleate) are not toxic and can protect against the detrimental effects of palmitate. In the present study, we show that the protective actions of palmitoleate in BRIN-BD11 β-cells result in attenuated caspase activation following exposure to palmitate and that a similar response occurs in cells having elevated levels of cAMP. However, unlike palmitoleate, elevation of cAMP was unable to prevent the cytotoxic actions of palmitate since it caused a diversion of the pathway of cell death from apoptosis to necrosis. Palmitoleate did not alter cAMP levels in BRIN-BD11 cells and the results suggest that a change in cAMP is not involved in mediating the protective effects of this fatty acid. Moreover, they reveal that attenuated caspase activation does not always correlate with altered cell viability in cultured β-cells and suggest that mono-unsaturated fatty acids control cell viability by regulating a different step in the apoptotic pathway from that influenced by cAMP.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107
Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M (2005) Mechanisms of β-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108–S113
Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589
Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration? Diabetologia 48:2221–2228
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Li L, El-Kholy W, Rhodes CJ, Brubaker PL (2005) Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: Role of protein kinase B. Diabetologia 48:1339–1349
Montolio M, Tellez N, Biarnes M, Soler J, Montanya E (2005) Short-term culture with the caspase inhibitor z-VAD. fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft. Cell Transplant 14:59–65
Ou D, Wang X, Metzger DL, James RF, Pozzilli P, Plesner A, Korneluk RG, Verchere CB, Tingle AJ (2005) Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Hum Immunol 66:274–284
Karlsen AE, Heding PE, Frobose H, et al (2004) Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated pro-apoptotic pathways. Diabetologia 47:1998–2011
Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M (2004) Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47:806–815
Kwon G, Pappan KL, Marshall CA, Schaffer JE, McDaniel ML (2004) cAMP dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells. J Biol Chem 279:8938–8945
Drucker DJ (2003) Glucagon-like peptide-1 and the islet beta-cell: Augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145–5148
Welters HJ, Tadayyon M, Scarpello JH, Smith SA, Morgan NG (2004) Mono-unsaturated fatty acids protect against beta-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Lett 560:103–108
Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52:726–733
Eitel K, Staiger H, Brendel MD, et al (2002) Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 299:853–856
Beeharry N, Chambers JA, Green IC (2004) Fatty acid protection from palmitic acid-induced apoptosis is lost following PI3-kinase inhibition. Apoptosis 9:599–607
Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y, McIntosh CH (2005) Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase/protein kinase B signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 280:22297–22307
Wideman RD, Kieffer TJ (2004) Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fate. Horm Metab Res 36:782–786
Bregenholt S, Moldrup A, Blume N, et al (2005) The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem Biophys Res Commun 330:577–584
Brubaker PL, Drucker DL (2004) Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145:2653–2659
Itoh Y, Kawamata Y, Harada M, et al (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173–176
Briscoe CP, Tadayyon M, Andrews JL, et al (2003) The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:11303–11311
Salehi A, Flodgren E, Nilsson NE, et al (2005) Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 322:207–215
Feng DD, Luo Z, Roh SG, Hernandez M, Tawadros N, Chen C (2005) Reduction in voltage-gated K+ currents in primary cultured rat pancreatic β-cells by linoleic acids. Endocrinology doi: 10.1210/en.2005-0225.
Welters HJ, Smith SA, Tadayyon M, Scarpello JH, Morgan NG (2004) Evidence that protein kinase Cδ is not required for palmitate-induced cytotoxicity in BRIN-BD11 beta-cells. J Mol Endocrinol 32:227–235
Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777
Miller TA, LeBrasseur NK, Cote GM, et al (2005) Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun 336:309–315
Cacicedo JM, Benjachareowong S, Chou E, Ruderman NB, Ido Y (2005) Palmitate-induced apoptosis in cultured bovine retinal pericytes: Roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 54:1838–1845
Mishra R, Simonson MS (2005) Saturated free fatty acids and apoptosis in microvascular mesangial cells: Palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G. Cardiovasc Diabetol 4:2 doi:10.1186/1475-2840-4-2
Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870
El-Assaad W, Buteau J, Peyot M-L, et al (2003) Saturated fatty acids synergise with elevated glucose to cause pancreatic β-cell death. Endocrinology 144:4154–4163
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Welters, H.J., Diakogiannaki, E., Mordue, J.M. et al. Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic β-cells exposed to palmitate. Apoptosis 11, 1231–1238 (2006). https://doi.org/10.1007/s10495-006-7450-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-006-7450-7